Drug discovery

Register now to join this unique online event. Hosted by DDW and sponsored by ACRO Biosystems, ‘Innovative advances in neuroscience’ will be free to attend on 8 November 2023 at 7AM PST / 10AM EST / 3PM GMT / 4PM CET. You will hear from Fiona Elwood, VP, Disease Area Stronghold Lead, Neurodegeneration, Janssen, and Jenny […]

Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory, has opened the Early Adopter Programme for its SemaCyte Microcarrier Platform. The platform aims to overcome the limitations associated with adherent cell culture and assaying workflows by enabling small colonies of cells to be moved and frozen in their adherent state, increasing the volume […]

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The buzz with week has been around Phase I trials, with new therapies for lung cancer, geographic atrophy, Parkinson’s, sarcopenia and long Covid […]

Professor Henrik Daub, Founder and CSO, NEOsphere Biotechnologies looks at the advancements taking place in proteomics and how targeted protein degradation represents a promising approach for developing new treatments for life-threatening diseases.   Advancements in proteomics using mass spectrometry are helping researchers to identify novel, previously undruggable targets and develop degrader drugs to treat life-threatening […]

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. Here, DDW’s Megan Thomas highlights the research taking place and where this is happening. The Golden Triangle Though the UK is constantly expanding in terms of where drug discovery can flourish geographically, there is no denying both the historical and the […]

News round-up for 9-13 October by DDW Digital Content Editor Diana Spencer. The buzz with week has been around Phase I trials, with new therapies for lung cancer, geographic atrophy, Parkinson’s, sarcopenia and long Covid demonstrating positive early results or entering clinical trials for the first time. The top stories: Non-viral gene therapy shows early […]

French start-ups Pasqal and Qubit Pharmaceuticals are among the 12 selected performers for the Quantum for Bio programme in consortium with the Unitary Fund. Together with the Unitary Fund, Pasqal and Qubit will receive $4.5 million of the total $40 million awarded through the various milestones under the Quantum for Bio programme. The goal of […]

Hosted by DDW and sponsored by ACRO Biosystems, ‘Innovative advances in neuroscience’ will be free to attend on 8 November 2023 at 7AM PDT / 10AM EST / 3PM GMT / 4PM CET. Join this free webinar to learn about innovation taking place in the neuroscience field. You will hear from Fiona Elwood, VP, Disease […]

ELRIG’s Drug Discovery 2023 will be taking place at ACC Liverpool, UK from 18-19 October 2023, focusing on the importance of a diverse life science ecosystem. Megan Thomas caught up with those planning to attend this year. New approaches and thought processes When it comes to diversity in drug discovery, this includes our scientists’ and […]

Over recent months, there have been a number of ground-breaking discoveries in drug discovery for mental health conditions. A new class of antidepressants In July 2023, AlzeCure Pharma published the results of a preclinical study supporting the antidepressive effects ACD856, the first in a new class of antidepressants. The article in the journal Psychopharmacology focuses […]

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In celebration of the Nobel Prize for Medicine going to two of the early proponents of mRNA technology for creating therapeutics, Katalin Karikó […]

Hosted by DDW and co-sponsored by Benchling and Proscia, “AI and Lab Automation: What are the key benefits and latest innovations?” will be free to attend on 10 October at 7AM PDT / 10AM EST / 3PM BST / 4PM CET. Join this free webinar to learn about the key benefits and latest innovations to […]

News round-up for 2-6 October by DDW Digital Content Editor Diana Spencer. In celebration of the Nobel Prize for Medicine going to two of the early proponents of mRNA technology for creating therapeutics, Katalin Karikó and Drew Weissman, this week our round-up highlights the importance of genetics, genomics and gene editing in drug discovery. The […]

Join DDW’s Megan Thomas and Reece Armstrong with sponsor Taconic Biosciences for the first DDW Turning Science into Business Summit, ‘Cancer research opportunities and advances’, on 16 November at 7AM PDT / 10AM EST / 3PM GMT / 4PM CET. This free 2-hour Summit will take place online and will outline areas of advancement and […]

The webinar ‘Generative AI: Turning drug discovery into a technological pursuit’ supported by Thermo Fisher Scientific and presented by Generate:Biomedicines will be free to attend on 12 October 9am EDT / 2pm BST / 3pm CEST. The webinar, hosted by DDW, will feature the expertise of Adam Root, Vice President, Protein Sciences at Generate:Biomedicines who […]

Join DDW for its Turning Science into Business Summit: Cancer research opportunities and advances. This free online event will be hosted by DDW and is sponsored by Taconic Biosciences. The 2-hour Summit will outline areas of advancement and opportunity in the cancer research market and will consist of presentations from experts in the field, as […]